Vera Therapeutics, Inc.

NASDAQ:VERA

28.18 (USD) • At close March 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -43.425-46.632-33.708-28.383-25.655-20.104-20.162-30.069-32.439-24.679-14.853-17.085-16.847-7.611-3.437-4.714-42.875-4.46-3.604-2.474
Depreciation & Amortization 0.0550.0241.495-0.952-0.635-1.442-0.971-0.506-0.597-0.152-0.1060.0090.0320.0590.050.035-0.6420.6730.1120.108
Deferred Income Tax 0000-3.1330.0150.029000000.2470.364-2.41001.18500
Stock Based Compensation 6.2175.5884.8734.1243.2212.9232.6822.6672.7482.4522.0251.6620.9620.9330.7130.4040.1430.1160.0110.061
Change In Working Capital -0.7285.8636.144-8.619-2.077-4.9140.0861.0368.536-0.465-7.1935.8694.2920.896-2.4210.7440.051-0.3470.4070.012
Accounts Receivables 00000000000000000000
Change In Inventory 00000000000000000000
Change In Accounts Payables 3.063-0.062-0.545-5.909-1.182-0.987.954-6.6654.979-0.072-0.2445.9430.42-0.7591.012-0.1980.57-0.3890.3830.003
Other Working Capital -3.7915.9256.689-2.71-0.895-3.934-7.8686.6653.557-0.393-0.007-0.0743.8721.655-3.4330.942-0.5190.0420.0240.009
Other Non Cash Items -1.301-1.7283.3278.1293.1350.5490.5640.580.594.4240.5510.5644.876-0.125-0.16-0.5915.9410.3860.399-0.012
Operating Cash Flow -39.182-36.885-24.782-33.83-25.144-22.973-17.772-26.292-21.162-18.42-19.033-8.981-6.438-5.484-7.665-4.121-27.382-2.447-2.675-2.305
Investing Activities:
Investments In Property Plant And Equipment -0.645-25.10924.7820-0.063000-0.006-0.038-0.006-0.018000000-0.047-0.052
Acquisitions Net 0000-0.01900000.00200000.79600000
Purchases Of Investments -294.015-72.945-81.088-254.967-53.2-28.672-108.849-34.209-10.563-40.403-58.087-39.43700000000
Sales Maturities Of Investments 73.277111.558.535.68171.81944.922.446.4432438.00115.999000000000
Other Investing Activites 024.871-0.089-0.2190.0190.016-0.0860.0120.006-0.002-0.042-0.039-500.79600.057000
Investing Cash Flow -221.38338.317-22.677-219.28618.55616.228-86.44912.23413.437-2.44-42.094-39.455-500.79600.0570-0.047-0.052
Financing Activities:
Debt Repayment 000000000000000.001-0.001-0.018-0.0320.574.952
Common Stock Issued 34503.439287.5370.0870.2970.432115-0.0010.0010.00186.130.55051.176-0.0270000
Common Stock Repurchased 0-0.013000000000000000-000
Dividends Paid 00000000000000000000
Other Financing Activities -19.0450.7523.439-10.99724.8280.2970.432-7.01620.7090.9070.047-5.8624.9210-2.188-0.02779.819-0.0620.0460.015
Financing Cash Flow 325.9550.7393.439276.5424.8280.2970.432107.98420.7090.9080.04880.2684.921048.989-0.02879.801-0.0940.6164.967
Other Information:
Effect Of Forex Changes On Cash 0000-115.8429.371106.4710000000000000
Net Change In Cash 65.392.171-44.0223.42418.24-6.448-103.78993.92612.984-19.952-61.07931.832-6.517-5.48442.12-4.14952.476-2.541-2.1062.61
Cash At End Of Period 92.64627.25625.08569.10545.68127.44133.889137.67843.75230.76850.72111.79979.96786.48491.96849.84853.9971.5214.0626.168